Zhou Yan, Liu Min, Huang Xing, Liu Zhen, Sun Yun, Wang Minjie, Huang Tao, Wang Xianke, Chen Long, Jiang Xiaobing
Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.
Front Oncol. 2024 Jan 12;13:1307924. doi: 10.3389/fonc.2023.1307924. eCollection 2023.
This study aims to depict the scientific advancements in immunotherapy for glioma by analyzing the top 100 most frequently cited articles over the past 20 years.
The top 100 most influential papers in immunotherapy for glioma were identified from the Web of Science Core Collection. Citations, countries/regions, institutions, journals, authorships, keywords, and references were extracted and analyzed by CiteSpace, VOSviewer, R software, and an online bibliometric platform.
The United States possessed a robust global presence, leading in terms of publications and maintaining strong collaborative ties with numerous countries. The institution that made the greatest contributions was Duke University, with 16 papers. Heimberger AB, Sampson JH, and Reardon DA secured the top three positions with 15, 12, and 11 papers, respectively. "Macrophage ontogeny," "microglia," "polarization," "mass cytometry," "tumor mutation burden," "sensitivity," "msh6," "pd-1 blockade," and "dna repair" were the recent hot keywords. "Microglia" and "polarization" as the emerging research directions should be given more consideration.
This is the first bibliometric analysis to identify the top 100 papers on immunotherapy for glioma. "Microglia" and "polarization" will be hot spots for future research. The clinical efficacy of glioma immunotherapy is not yet satisfactory, and there is an urgent need to search for more tumor specific antigens and targets that can assist in early diagnosis, precise treatment, prognosis, and recurrence prediction of glioma.
本研究旨在通过分析过去20年中被引用次数最多的100篇文章,描绘胶质瘤免疫治疗的科学进展。
从科学网核心合集中确定胶质瘤免疫治疗领域最具影响力的100篇论文。通过CiteSpace、VOSviewer、R软件和一个在线文献计量平台提取并分析引用次数、国家/地区、机构、期刊、作者身份、关键词和参考文献。
美国在全球占据主导地位,在出版物数量方面领先,并与许多国家保持着紧密的合作关系。贡献最大的机构是杜克大学,有16篇论文。Heimberger AB、Sampson JH和Reardon DA分别以15篇、12篇和11篇论文位居前三。“巨噬细胞个体发生”“小胶质细胞”“极化”“质谱流式细胞术”“肿瘤突变负荷”“敏感性”“msh6”“pd-1阻断”和“DNA修复”是近期的热门关键词。“小胶质细胞”和“极化”作为新兴的研究方向应得到更多关注。
这是首次对胶质瘤免疫治疗领域的100篇顶级论文进行文献计量分析。“小胶质细胞”和“极化”将是未来研究的热点。胶质瘤免疫治疗的临床疗效尚不令人满意,迫切需要寻找更多能够辅助胶质瘤早期诊断、精准治疗、预后评估和复发预测的肿瘤特异性抗原和靶点。